Botulinum toxin therapy for neurologic disorders
- 17 May 1992
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 91 (6) , 327-334
- https://doi.org/10.1080/00325481.1992.11701332
Abstract
Botulinum toxin type A, the most potent biologic neurotoxin known, enjoys a curious role as an increasingly used therapeutic agent. Its ability to produce chemical denervation in muscle makes it an intriguing option for treating focal dystonias and other neurologic disorders in which traditional therapies are of limited benefit. In this article, Drs Tim and Massey describe the therapeutic effectiveness of botulinum toxin in various disorders.Keywords
This publication has 20 references indexed in Scilit:
- Assessment [RETIRED]Neurology, 1990
- Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spreadHead & Neck, 1990
- Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollisNeurology, 1990
- Brachial plexopathy after botulinum toxin injectionsNeurology, 1990
- Treatment of Blepharospasm With Botulinum ToxinMayo Clinic Proceedings, 1989
- Botulinum Toxin Injections in the Treatment of Blepharospasm, Hemifacial Spasm, and Eyelid FasciculationsCanadian Journal of Neurological Sciences, 1988
- Botulinum toxin for blepharospasm: single-fiber EMG studiesNeurology, 1986
- Botulinum Toxin in the Management of BlepharospasmArchives of Neurology, 1986
- Etiology and definitive microsurgical treatment of hemifacial spasmJournal of Neurosurgery, 1977
- Influence of nerve‐ending activity and of drugs on the rate of paralysis of rat diaphragm preparation by Cl. botulinum type A toxinThe Journal of Physiology, 1962